Ameriprise’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,489
Closed -$33.2K 3947
2024
Q2
$33.2K Sell
1,489
-6,728
-82% -$150K ﹤0.01% 3832
2024
Q1
$483K Sell
8,217
-3,155
-28% -$185K ﹤0.01% 3432
2023
Q4
$252K Sell
11,372
-1
-0% -$22 ﹤0.01% 3659
2023
Q3
$245K Buy
11,373
+10,420
+1,093% +$225K ﹤0.01% 3640
2023
Q2
$64.3K Sell
953
-35
-4% -$2.36K ﹤0.01% 3850
2023
Q1
$461K Sell
988
-122
-11% -$56.9K ﹤0.01% 3460
2022
Q4
$445K Buy
1,110
+3
+0.3% +$1.2K ﹤0.01% 3447
2022
Q3
$360K Buy
+1,107
New +$360K ﹤0.01% 3508
2021
Q4
Sell
-1,177
Closed -$301K 3983
2021
Q3
$301K Sell
1,177
-769
-40% -$197K ﹤0.01% 3571
2021
Q2
$1.3M Sell
1,946
-789
-29% -$525K ﹤0.01% 3111
2021
Q1
$2.37M Sell
2,735
-210
-7% -$182K ﹤0.01% 2793
2020
Q4
$2.73M Sell
2,945
-55
-2% -$51K ﹤0.01% 2631
2020
Q3
$3.08M Sell
3,000
-666
-18% -$685K ﹤0.01% 2406
2020
Q2
$3.71M Sell
3,666
-928
-20% -$940K ﹤0.01% 2271
2020
Q1
$3.99M Buy
4,594
+366
+9% +$318K ﹤0.01% 2058
2019
Q4
$4.53M Buy
4,228
+128
+3% +$137K ﹤0.01% 2294
2019
Q3
$3.79M Sell
4,100
-321
-7% -$297K ﹤0.01% 2355
2019
Q2
$4.99M Sell
4,421
-1,845
-29% -$2.08M ﹤0.01% 2251
2019
Q1
$8.51M Buy
6,266
+4,820
+333% +$6.55M ﹤0.01% 1835
2018
Q4
$1.67M Sell
1,446
-836
-37% -$967K ﹤0.01% 2719
2018
Q3
$3.47M Buy
2,282
+202
+10% +$307K ﹤0.01% 2573
2018
Q2
$3.26M Buy
2,080
+1,032
+98% +$1.61M ﹤0.01% 2506
2018
Q1
$1.21M Sell
1,048
-11
-1% -$12.7K ﹤0.01% 2885
2017
Q4
$1.26M Sell
1,059
-277
-21% -$328K ﹤0.01% 2873
2017
Q3
$1.8M Buy
+1,336
New +$1.8M ﹤0.01% 2665
2016
Q2
Sell
-2,921
Closed -$1.56M 3781
2016
Q1
$1.56M Sell
2,921
-230
-7% -$122K ﹤0.01% 2638
2015
Q4
$2.4M Buy
3,151
+579
+23% +$441K ﹤0.01% 2490
2015
Q3
$1.41M Buy
+2,572
New +$1.41M ﹤0.01% 2794